Willis Investment Counsel Gsk PLC Transaction History

Willis Investment Counsel

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $3.76 Million - $4.07 Million	-95,400 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$38.57 - $42.69 $17.4 Million - $19.3 Million	-451,400 Reduced 82.55%	95,400 $8.11 Million
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $238,139 - $268,947	-6,300 Reduced 1.14%	546,800 $20.9 Million
Q3 2018 Nov 15, 2018	SELL	$39.75 - $42.69 $1.71 Million - $1.83 Million	-42,900 Reduced 7.2%	553,100 $22.2 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $689,214 - $744,024	-17,400 Reduced 2.84%	596,000 $24 Million
Q1 2018 May 11, 2018	BUY	$36.18 - $40.15 $3.24 Million - $3.59 Million	89,500 Added 17.08%	613,400 $24 Million
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $307,458 - $364,530	8,700 Added 1.69%	523,900 $18.6 Million
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $20.3 Million - $21.4 Million	515,200	515,200 $20.9 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Willis Investment Counsel with notifications on news.